# Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed

> **NCT00002707** · PHASE3 · COMPLETED · sponsor: **NSABP Foundation Inc** · enrollment: 2411 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Cyclophosphamide
- **DRUG:** Docetaxel
- **DRUG:** Doxorubicin
- **DRUG:** Tamoxifen

## Key facts

- **NCT ID:** NCT00002707
- **Lead sponsor:** NSABP Foundation Inc
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-12
- **Primary completion:** 2002-06
- **Final completion:** 2010-02
- **Target enrollment:** 2411 (ACTUAL)
- **Last updated:** 2010-02-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002707, "Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00002707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*